68 related articles for article (PubMed ID: 7022888)
1. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
[No Abstract] [Full Text] [Related]
2. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
Abouna GM; Garver FA; Kogure H; DeLong TG; Andres GA
Surg Forum; 1973; 24():318-20. PubMed ID: 4618655
[No Abstract] [Full Text] [Related]
3. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments.
Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE
Surg Forum; 1975; 26():311-3. PubMed ID: 814638
[No Abstract] [Full Text] [Related]
4. Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
Genevaz D; Latremouille C; Goussev N; Carpentier A; Glotz D
Transplant Proc; 1996 Apr; 28(2):853-4. PubMed ID: 8623433
[No Abstract] [Full Text] [Related]
5. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
[No Abstract] [Full Text] [Related]
6. Preliminary results with passive enhancement in human kidney transplantation.
Solheim BG; Flatmark A; Thorsby E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.
Chatterjee SN; Smith R; Fine S; Schulman B; Fine RN
Transplant Proc; 1981 Mar; 13(1 Pt 2):709-11. PubMed ID: 7022938
[No Abstract] [Full Text] [Related]
8. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
[No Abstract] [Full Text] [Related]
9. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
Martins AC; Wren SF; Busch GJ; MacPherson SG; von Haefen U; Wilson RE
AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
[No Abstract] [Full Text] [Related]
10. Persistence of passively transferred goat F(ab')2 antibody fragments in the circulation of rodents.
Nelson SJ; Manning DD
J Immunol; 1980 Nov; 125(5):2339-43. PubMed ID: 6776191
[No Abstract] [Full Text] [Related]
11. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
[No Abstract] [Full Text] [Related]
12. Effect of anti-Fab antibodies on renal allografts.
Feduska NJ; Chia D; Terasaki PI; Sugich L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1277-8. PubMed ID: 1989211
[No Abstract] [Full Text] [Related]
13. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
Ahlmén J; Gustafsson A; Claes G; Kaijser B; Svalander C; Gelin L
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):51-2. PubMed ID: 781817
[TBL] [Abstract][Full Text] [Related]
14. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
Quadri SM; Lai J; Mohammadpour H; Vriesendorp HM; Williams JR
J Nucl Med; 1993 Dec; 34(12):2152-9. PubMed ID: 8254403
[TBL] [Abstract][Full Text] [Related]
15. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment.
Corman JL; Kashiwagi N; Porter KA; Andres G; Iwatsuki S; Putnam CW; Popovtzer M; Penn I; Starzl TE
Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857
[No Abstract] [Full Text] [Related]
16. Enhancement of canine renal allografts. II. Studies with Fab fragments.
Martin DC; Blackwelder R; Rasband R; Morton ME
Trans Am Assoc Genitourin Surg; 1976; 68():99-101. PubMed ID: 801216
[No Abstract] [Full Text] [Related]
17. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
18. A quantitative comparison of whole antibody and F(ab')2 in kidney allograft enhancement.
Winearls CG; Fabre JW; Millard PR; Morris PJ
Transplantation; 1979 Jul; 28(1):36-9. PubMed ID: 377591
[TBL] [Abstract][Full Text] [Related]
19. A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope.
Terness P; Navolan D; Moroder L; Siedler F; Weyher E; Kohl I; Dufter C; Welschof M; Drugarin D; Schneider F; Opelz G
J Immunol; 1996 Nov; 157(9):4251-7. PubMed ID: 8892664
[TBL] [Abstract][Full Text] [Related]
20. Use of cyproheptadine in human cadaver transplantation: a controlled randomized prospective study.
Rattazzi LC; Simmons RL; Najarian JS
Transplant Proc; 1977 Mar; 9(1):985-7. PubMed ID: 325833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
